Cabaletta Bio's market cap is currently $200.31M. The company's EPS TTM is $-0.73; its P/E ratio is ―; Cabaletta Bio is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.
